Integer Holdings Corp (ITGR) Shares Sold by Systematic Financial Management LP

Systematic Financial Management LP lowered its position in Integer Holdings Corp (NYSE:ITGR) by 1.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 14,755 shares of the medical equipment provider’s stock after selling 165 shares during the quarter. Systematic Financial Management LP’s holdings in Integer were worth $1,113,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Norges Bank purchased a new position in Integer during the fourth quarter valued at $30,458,000. American Century Companies Inc. lifted its position in Integer by 158.3% during the fourth quarter. American Century Companies Inc. now owns 379,748 shares of the medical equipment provider’s stock valued at $28,960,000 after purchasing an additional 232,702 shares in the last quarter. WINTON GROUP Ltd purchased a new position in Integer during the fourth quarter valued at $10,747,000. Emerald Mutual Fund Advisers Trust lifted its position in Integer by 35.9% during the fourth quarter. Emerald Mutual Fund Advisers Trust now owns 327,312 shares of the medical equipment provider’s stock valued at $24,961,000 after purchasing an additional 86,458 shares in the last quarter. Finally, Emerald Advisers LLC lifted its position in Integer by 27.1% during the fourth quarter. Emerald Advisers LLC now owns 365,157 shares of the medical equipment provider’s stock valued at $27,847,000 after purchasing an additional 77,916 shares in the last quarter. 93.84% of the stock is owned by institutional investors.

Shares of Integer stock traded down $1.68 during trading hours on Monday, hitting $69.16. The company’s stock had a trading volume of 1,081 shares, compared to its average volume of 343,885. Integer Holdings Corp has a 12-month low of $62.80 and a 12-month high of $92.61. The company has a market capitalization of $2.31 billion, a price-to-earnings ratio of 18.11 and a beta of 0.91. The company has a quick ratio of 1.49, a current ratio of 2.55 and a debt-to-equity ratio of 0.84.



Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, May 2nd. The medical equipment provider reported $1.00 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.80 by $0.20. Integer had a return on equity of 13.37% and a net margin of 14.67%. The business had revenue of $314.70 million for the quarter, compared to the consensus estimate of $302.29 million. During the same period in the previous year, the business earned $0.61 earnings per share. The business’s revenue was up 7.6% on a year-over-year basis. On average, equities analysts expect that Integer Holdings Corp will post 4.3 earnings per share for the current year.

In other news, insider Jose Antonio Gonzalez sold 9,088 shares of Integer stock in a transaction dated Thursday, February 28th. The stock was sold at an average price of $90.88, for a total value of $825,917.44. Following the sale, the insider now directly owns 11,899 shares of the company’s stock, valued at $1,081,381.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Donald J. Spence sold 50,559 shares of Integer stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $85.41, for a total value of $4,318,244.19. Following the completion of the sale, the director now directly owns 41,285 shares in the company, valued at $3,526,151.85. The disclosure for this sale can be found here. Insiders sold 62,147 shares of company stock worth $5,358,962 over the last 90 days. Company insiders own 2.24% of the company’s stock.

Several equities analysts recently weighed in on the company. Zacks Investment Research downgraded Integer from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, April 24th. ValuEngine downgraded Integer from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Finally, Royal Bank of Canada boosted their price objective on Integer from $84.00 to $92.00 and gave the company a “sector perform” rating in a research report on Monday, February 25th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Integer has a consensus rating of “Buy” and a consensus price target of $89.40.

WARNING: “Integer Holdings Corp (ITGR) Shares Sold by Systematic Financial Management LP” was published by Dakota Financial News and is the sole property of of Dakota Financial News. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://dakotafinancialnews.com/2019/05/20/integer-holdings-corp-itgr-shares-sold-by-systematic-financial-management-lp.html.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.

Recommended Story: What economic reports are most valuable to investors?

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corp (NYSE:ITGR).

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.